David Lund
Analyst · Compass Point. Please go ahead. Your line is open
Thank you, Kyle. And thank you everyone for joining us on today's call. Following our first quarter as a public company, we extended the momentum and delivered strong results across all key financial metrics, delivering record originations and net portfolio growth, as well as maintaining a high quality credit book with ample liquidity. My remarks today will cover our venture loan and equipment financing, portfolio growth and some drivers of our operating performance. On the latter I will focus specifically on return performance, credit performance and liquidity. Beginning with our portfolio growth, we had a record quarter of -- for commitments and funding during Q2 we entered into approximately $127 million of new commitments and deployed $122 million across 17 portfolio companies. This brings our commitments in the first half of 2021 to a record $251 million as we continue to prudently deploy capital and grow a diverse investment portfolio post IPO. We funded $115.4 million in secured loans 12 portfolio companies, we funded $5.5 million in equipment loans to three companies. And we made $1.5 million of equity investments in two portfolio companies. Gross deployments were partially offset by approximately $69 million in principal repayments, which is consistent with the $67 million in repayments we received in Q1. Of the $69 million in aggregate, $51 million was from early principal repayments and $18 million was from normal amortization. In addition, we received $11 million in proceeds from the sales of our warrant and equity investments. We believe that the elevated level of early repayments reflects the ability of many of our portfolio companies to raise new capital, scale their businesses and return our capital, generating strong returns to Trinity shareholders. As a result of the $42 million of net investment activity, and approximately $5 million of accretion OID and end of term payments and realized gains, our portfolio at cost grew by 9.4% to $575 million compared to $525 million at the end of Q1. On a fair value basis, our portfolio increased $536 million to $598 million attributed to the net deployments I discussed and $12.6 million of net unrealized appreciation. The increase in net unrealized appreciation was primarily attributed to mark-to-market improvements in our equity and warrant portfolios. And net unrealized appreciation of $7 million in our equity investments was principally driven by mark-to-market gains in Lucid. The net appreciation of $5.3 million in our [warrant] portfolio was primarily driven by mark-to-market adjustments in two portfolio companies including Matterport. As Kyle mentioned, Atieva completed its business combination with Churchill Capital Corp IV in July, becoming Lucid Group. The fair value of our equity position in Lucid increased by $11.4 million to $39.2 million from Q1 2021. As of August 4, in connection with the merger, we own approximately 1.9 million shares of common stock in Lucid. We’ve recorded an unrealized appreciation of approximately $2.7 million on our warrant position in Matterport. Matterport also completed its back merger in July, and subsequent to quarter-end, we exercised our warrant. As of August 4, we hold approximately 572,000 shares of common stock in Matterport. Approximately 49% of our debt portfolio is in floating rate securities up from 32% at the end of Q1. As we continue our planned transition to floating rate loans. Our move to floating rate loans will reduce our exposure to interest rate fluctuations, and net interest margin compression. I will now turn to our operating results. On a GAAP basis, we recorded total investment income of $19.5 million comprised of approximately $18.1 million in interest income, and $1.4 million in fee income. This represents a $2.2 million or 12.5% increase over the $17.3 million of total investment income recorded during the first quarter and the year-over-year increase of 41% over the $13.8 million recorded in Q2 2020. Similarly, looking at the year-to-date period, total investment income increased by 41% to $36.8 million from $26.1 million in the first half of 2020. This increase was primarily related to the higher average debt investments outstanding and higher effective portfolio yields and amortization of OID. Our effective yield on the portfolio for Q2 was 15.9%, which increased from slightly from 15.5% in the prior quarter driven primarily by pre-payment fees and accelerated OID from early repayments. For the six month period, effective yields were 15.8% as compared to 14.8% in the prior year period. We incurred a total of $4.4 million of total expense and amortization of deferred financing costs on various debt facilities relatively steady compared to $4.6 million in Q1. These costs are primarily comprised of interest and fees related to our credit facility, the unsecured 7% notes and the 6% convertible notes. For Q2, our weighted average cost of debt, including interest and fee amortization was 7.6%, which was an increase from 7.2% in the previous quarter. The increase was primarily driven by the amortization expense of the credit facility origination costs against a lower average debt balance outstanding under the Credit Suisse facility in Q2. Moving into other operating expenses, Q2 employee compensation expense was $3.4 million, compared to $4 million in Q1 and $4.5 million in Q4 2020. The decrease is attributed to lower variable compensation expenses and is expected to reach a more normalized run rate over this near-term. Q2 professional fees were $570,000 compared to $647,000 during Q1 and $731,000 in Q4 2020. The decrease is primarily attributed to professional and valuation fees offset by higher IT consulting fees. Q2 G&A expense was $1 million compared to $808,000 in Q1 and $486,000 during Q4 2020. The increase in G&A expense continues to be driven primarily by higher D&O insurance expense as a public company and higher rent expense for our new headquarters in downtown Phoenix. As a result of the activity noted previously, net investment income for the second quarter was $10.1 million or $0.38 per share. This compares to $7.3 million or $0.31 per share in the preceding quarter and $5.3 million or $0.29 per share in Q4 2020. During the second quarter, we’ve recognize net realized gains of $2 million primarily related to our equity investment in Ology Bioservices as well as the conversion of warrant in two portfolio companies. As I noted earlier, we recorded net unrealized appreciation of $12.6 million primarily driven by the mark-to -market changes in the fair value of our equity and warrant portfolio. The unrealized appreciation is net of $3.2 million of unrealized appreciation that flip to realize gains in Q2. Q2 2021 net assets worth $380 million or NAV of $14.33 per share, which compares favorably to Q1 net assets of approximately $362 million or NAV of $13.69 per share. The quarter-over-quarter increase of $0.64 per share NAV was primarily the result of unrealized appreciation and realized gains recognized during the second quarter and net investment income that exceeded our declared dividend by $0.09 per share. Our credit quality remains strong with over 99% of our portfolio performing. We currently have two portfolio companies on non-accrual with a carrying cost of $1.2 million and a fair value of $0.9 million, representing just 18 basis points on the debt investment portfolio. Our average risk rating for the quarter was 3.1, based on our one to five risk rating scale, with five indicating very strong performance. Turning now to liquidity. Available liquidity as of June 30, 2021 was approximately $107.7 million, including approximately $19.1 million in cash and cash equivalents and a borrowing capacity of $88.6 million under our credit facility subject to existing terms and conditions. End of period leverage was 65% and our asset coverage ratio was 258%. Regarding our dividend, on June 15, 2021, we declared a cash dividend of $0.29 per share for the second quarter of 2021 that was paid on July 15. And which generated 131% coverage by our GAAP NII earnings for the quarter. We anticipate declaring a dividend for the third quarter of 2021 during September subject to our Board of Directors approval. Finally, to further enhance our liquidity position on July 9, we filed a shelf registration statement with the SEC, which will provide greater flexibility to raise additional debt or equity capital to support the growth of Trinity's platform. With that, I'll now open the line for questions. Rylan?